Parallax Volatility Advisers, L.P. 2seventy Bio, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 21,186 shares of TSVT stock, worth $52,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,186Holding current value
$52,965% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TSVT
# of Institutions
127Shares Held
44.8MCall Options Held
17.3KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$14.9 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.29MShares$10.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$9.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$9.15 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$7.29 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $94.7M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...